258 related articles for article (PubMed ID: 34267352)
1. A phosphatidic acid-binding lncRNA SNHG9 facilitates LATS1 liquid-liquid phase separation to promote oncogenic YAP signaling.
Li RH; Tian T; Ge QW; He XY; Shi CY; Li JH; Zhang Z; Liu FZ; Sang LJ; Yang ZZ; Liu YZ; Xiong Y; Yan Q; Li X; Ju HQ; Liu J; Wang LJ; Shao JZ; Wang W; Zhou T; Lin A
Cell Res; 2021 Oct; 31(10):1088-1105. PubMed ID: 34267352
[TBL] [Abstract][Full Text] [Related]
2. Liquid-Liquid Phase Separation of DDR1 Counteracts the Hippo Pathway to Orchestrate Arterial Stiffening.
Liu J; Wang J; Liu Y; Xie SA; Zhang J; Zhao C; Zhou Y; Pang W; Yao W; Peng Q; Wang X; Zhou J
Circ Res; 2023 Jan; 132(1):87-105. PubMed ID: 36475898
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA LOC107985656 represses the proliferation of hepatocellular carcinoma cells through activation of the tumor-suppressive Hippo pathway.
Zeng Y; Xu Q; Xu N
Bioengineered; 2021 Dec; 12(1):7964-7974. PubMed ID: 34565286
[TBL] [Abstract][Full Text] [Related]
4. Calmodulin activates the Hippo signaling pathway by promoting LATS1 kinase-mediated inhibitory phosphorylation of the transcriptional coactivator YAP.
Thines L; Gorisse L; Li Z; Sayedyahossein S; Sacks DB
J Biol Chem; 2022 May; 298(5):101839. PubMed ID: 35307353
[TBL] [Abstract][Full Text] [Related]
5. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
Mana-Capelli S; McCollum D
J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
[TBL] [Abstract][Full Text] [Related]
6. TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer.
Han Y; Tang Z; Zhao Y; Li Q; Wang E
Mol Carcinog; 2018 Feb; 57(2):159-166. PubMed ID: 28926138
[TBL] [Abstract][Full Text] [Related]
7. LncRNA modulates Hippo-YAP signaling to reprogram iron metabolism.
He XY; Fan X; Qu L; Wang X; Jiang L; Sang LJ; Shi CY; Lin S; Yang JC; Yang ZZ; Lei K; Li JH; Ju HQ; Yan Q; Liu J; Wang F; Shao J; Xiong Y; Wang W; Lin A
Nat Commun; 2023 Apr; 14(1):2253. PubMed ID: 37080959
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of lncRNA LEF1-AS1 inhibited the progression of oral squamous cell carcinoma (OSCC) via Hippo signaling pathway.
Zhang C; Bao C; Zhang X; Lin X; Pan D; Chen Y
Cancer Biol Ther; 2019; 20(9):1213-1222. PubMed ID: 30983488
[TBL] [Abstract][Full Text] [Related]
9. Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases.
Adler JJ; Johnson DE; Heller BL; Bringman LR; Ranahan WP; Conwell MD; Sun Y; Hudmon A; Wells CD
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17368-73. PubMed ID: 24101513
[TBL] [Abstract][Full Text] [Related]
10. Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo-YAP signaling.
Zhou Y; Shan T; Ding W; Hua Z; Shen Y; Lu Z; Chen B; Dai T
J Cell Physiol; 2018 Aug; 233(8):5805-5814. PubMed ID: 29215734
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the Hippo Pathway by Phosphatidic Acid-Mediated Lipid-Protein Interaction.
Han H; Qi R; Zhou JJ; Ta AP; Yang B; Nakaoka HJ; Seo G; Guan KL; Luo R; Wang W
Mol Cell; 2018 Oct; 72(2):328-340.e8. PubMed ID: 30293781
[TBL] [Abstract][Full Text] [Related]
12. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
13. LncRNA UCA1 promotes migration and invasion in pancreatic cancer cells via the Hippo pathway.
Zhang M; Zhao Y; Zhang Y; Wang D; Gu S; Feng W; Peng W; Gong A; Xu M
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1770-1782. PubMed ID: 29510195
[TBL] [Abstract][Full Text] [Related]
14. Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.
Huntoon CJ; Nye MD; Geng L; Peterson KL; Flatten KS; Haluska P; Kaufmann SH; Karnitz LM
Cancer Res; 2010 Nov; 70(21):8642-50. PubMed ID: 20841485
[TBL] [Abstract][Full Text] [Related]
15. PIP5Kγ Mediates PI(4,5)P2/Merlin/LATS1 Signaling Activation and Interplays with Hsc70 in Hippo-YAP Pathway Regulation.
Le DDT; Le TPH; Lee SY
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834234
[TBL] [Abstract][Full Text] [Related]
16. Long non‑coding RNA
Wang K; Hu YB; Zhao Y; Ye C
Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33576454
[TBL] [Abstract][Full Text] [Related]
17. Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1.
Si Y; Ji X; Cao X; Dai X; Xu L; Zhao H; Guo X; Yan H; Zhang H; Zhu C; Zhou Q; Tang M; Xia Z; Li L; Cong YS; Ye S; Liang T; Feng XH; Zhao B
Cancer Res; 2017 Sep; 77(18):4868-4880. PubMed ID: 28754671
[TBL] [Abstract][Full Text] [Related]
18. WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy.
Qi S; Zhu Y; Liu X; Li P; Wang Y; Zeng Y; Yu A; Wang Y; Sha Z; Zhong Z; Zhu R; Yuan H; Ye D; Huang S; Ling C; Xu Y; Zhou D; Zhang L; Yu FX
Mol Cell; 2022 May; 82(10):1850-1864.e7. PubMed ID: 35429439
[TBL] [Abstract][Full Text] [Related]
19. T851I mutation of human large tumor suppressor 1 disrupts its kinase activity and tumor-suppressor functions.
Zhang Q; Du X; He Q; Shi W; Mei L; Qv M; Tan D; Wu J; Zeng LH; Wu X
Life Sci; 2021 Jan; 264():118655. PubMed ID: 33141042
[TBL] [Abstract][Full Text] [Related]
20. RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3.
Jang JW; Kim MK; Lee YS; Lee JW; Kim DM; Song SH; Lee JY; Choi BY; Min B; Chi XZ; Bae SC
Oncogene; 2017 Feb; 36(7):999-1011. PubMed ID: 27425596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
